SOLUBLE AND IMMUNOREACTIVE VARIANTS OF HTLV CAPSID ANTIGEN P24

    公开(公告)号:US20200033342A1

    公开(公告)日:2020-01-30

    申请号:US16577175

    申请日:2019-09-20

    IPC分类号: G01N33/569 C07K14/005

    摘要: The invention concerns soluble and antigenic HTLV p24 variants that can be fused to chaperones and their use in diagnostic applications such as immunoassays for detecting antibodies against HTLV-I or HTLV-II in an isolated biological sample. In particular, the invention relates to a soluble HTLV-I or HTLV-II p24 antigen comprising either the N- or the C-terminal domain of p24 and lacking the other domain. Moreover, the invention covers recombinant DNA molecules encoding these HTLV-I and -II fusion antigens as well as their recombinant production using expression vectors and host cells transformed with such expression vectors. In addition, the invention focuses on compositions of these HTLV p24 antigens with HTLV gp21 antigen and on an immunoassay method for detection of HTLV antibodies using the antigens of the invention. Also the use of HTLV p24 antigens in an in vitro diagnostic assay as well as a reagent kit for detection of anti-HTLV-antibodies comprising said HTLV antigens is encompassed.

    SOLUBLE IMMUNOREACTIVE TREPONEMA PALLIDUM TpN47 ANTIGENS
    4.
    发明申请
    SOLUBLE IMMUNOREACTIVE TREPONEMA PALLIDUM TpN47 ANTIGENS 有权
    可溶性免疫反应性TREPONEMA PALLIDUM TpN47抗原

    公开(公告)号:US20150079604A1

    公开(公告)日:2015-03-19

    申请号:US14335022

    申请日:2014-07-18

    IPC分类号: G01N33/571 C07K14/20

    摘要: The invention concerns soluble variants of Treponema pallidum antigen 47 (TpN47 antigen) comprising at least domain B, or at least domains A and B, optionally domain D of the complete TpN47 protein molecule with the proviso that all antigens lack domain C (amino acid residues 224 to 351) of TpN47. The Tpn47 antigens can be fused to a chaperone. Moreover, the invention covers DNA encoding the antigens, a method of producing these antigens as well as the use of these antigens in an immunodiagnostic assay for the detection of antibodies against Treponema pallidum in an isolated sample.

    摘要翻译: 本发明涉及包含至少结构域B或者至少结构域A和B,完全TpN47蛋白质分子的任选区域D的梅毒螺旋体抗原47(TpN47抗原)的可溶性变体,条件是所有抗原都缺乏结构域C(氨基酸残基 224〜351)TpN47。 Tpn47抗原可以融合到伴侣。 此外,本发明涵盖编码抗原的DNA,制备这些抗原的方法以及在免疫诊断测定中使用这些抗原来检测分离样品中针对梅毒螺旋体的抗体。

    SOLUBLE AND IMMUNOREACTIVE FLAVIVRAL NS1 POLYPEPTIDES

    公开(公告)号:US20220220158A1

    公开(公告)日:2022-07-14

    申请号:US17705704

    申请日:2022-03-28

    摘要: The disclosure relates to a polypeptide suitable for detecting antibodies against a flavivirus in an isolated biological sample having a flavivirus NS1 wing domain specific amino acid sequence, wherein no amino acid sequences from the NS1 β-ladder domain of said flavivirus are present in the polypeptide. In an embodiment, the flavivirus is selected from Zika virus (ZIKV), West-Nile virus (WNV), Dengue virus types 1-4 (DENV1-4), tick-borne encephalitis virus (TBEV), yellow fever virus (YFV) and Japanese encephalitis virus (JEV). Also disclosed is a method for producing said flaviviral NS1 wing domain specific polypeptides, a method for detecting antibodies specific for a first flavivirus species, the use of said flaviviral NS1 wing domain specific polypeptides for detecting antibodies as well as a reagent kit for detecting said flavivirus antibodies that has a flavivirus NS1 wing domain polypeptide.